The next decade is set to be a period of unprecedented expansion for the diabetes technology sector. According to the latest continuous glucose monitoring system market forecast, the global market value is projected to exceed USD 22 billion by 2032, maintaining a robust compound annual growth rate. This surge is fueled by a growing diabetic population and a significant shift in consumer preference toward non-invasive or minimally invasive monitoring solutions. Manufacturers are responding by developing sensors with extended wear times—some reaching up to 15 days—and smaller form factors that are virtually unnoticeable under clothing.

Emerging markets in the Asia-Pacific and Latin American regions are expected to be the primary engines of this future growth. As healthcare infrastructure improves and insurance coverage expands in these territories, the accessibility of high-end monitoring systems is reaching a wider demographic. The forecast also points toward a significant increase in the use of CGMs for gestational diabetes and professional point-of-care settings. By 2030, the "smart" integration of glucose data with automated insulin delivery (AID) systems will likely become the standard of care, creating a true "closed-loop" experience for patients.